Charles Schwab Investment Management Inc. Acquires 13,835 Shares of Perrigo Company plc (NYSE:PRGO)

Charles Schwab Investment Management Inc. grew its stake in Perrigo Company plc (NYSE:PRGO - Free Report) by 1.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,048,005 shares of the company's stock after purchasing an additional 13,835 shares during the period. Charles Schwab Investment Management Inc. owned about 0.77% of Perrigo worth $26,944,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Versant Capital Management Inc bought a new stake in Perrigo during the 4th quarter worth approximately $45,000. GAMMA Investing LLC grew its stake in shares of Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after purchasing an additional 929 shares during the last quarter. Central Pacific Bank Trust Division increased its holdings in Perrigo by 33.3% in the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock valued at $51,000 after purchasing an additional 500 shares during the period. Venturi Wealth Management LLC increased its holdings in Perrigo by 97.8% in the fourth quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company's stock valued at $108,000 after purchasing an additional 2,084 shares during the period. Finally, KBC Group NV lifted its holdings in Perrigo by 25.1% during the 3rd quarter. KBC Group NV now owns 4,517 shares of the company's stock worth $118,000 after buying an additional 905 shares during the period. 95.91% of the stock is owned by institutional investors.

Remove Ads

Insider Activity

In other news, EVP Ronald Craig Janish sold 7,800 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the sale, the executive vice president now owns 33,666 shares in the company, valued at $923,795.04. This represents a 18.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.70% of the company's stock.

Perrigo Stock Down 1.9 %

NYSE PRGO traded down $0.55 during mid-day trading on Friday, hitting $27.95. The company's stock had a trading volume of 679,540 shares, compared to its average volume of 1,438,102. The firm has a market capitalization of $3.81 billion, a price-to-earnings ratio of -23.88 and a beta of 0.48. The company's 50 day simple moving average is $25.66 and its 200 day simple moving average is $26.18. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. Perrigo Company plc has a twelve month low of $23.14 and a twelve month high of $33.46.

Perrigo (NYSE:PRGO - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.20 billion. Analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th will be paid a $0.29 dividend. The ex-dividend date of this dividend is Friday, March 7th. This is an increase from Perrigo's previous quarterly dividend of $0.28. This represents a $1.16 annualized dividend and a dividend yield of 4.15%. Perrigo's dividend payout ratio is -92.80%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on PRGO shares. StockNews.com lowered Perrigo from a "buy" rating to a "hold" rating in a research note on Wednesday, February 19th. Piper Sandler lowered shares of Perrigo from an "overweight" rating to a "neutral" rating and reduced their price objective for the company from $34.00 to $27.00 in a research note on Monday, January 6th. Finally, Argus downgraded shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $33.00.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.